TrialStem cell research & therapy2024

Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life.

Alexandre Sitbon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.